The identification of miRNAs involved in the regulation of the JAK/STAT pathway in patients harboring other mutations such as CALR and MPL would be valuable to increase the actual knowledge of the mechanisms involved in the pathogenesis of ET, but in the present work the low number of patients who harbored that mutations prevented the completion of the analysis. The gene discussed is MPL; the disease is essential thrombocythemia.